According to the author, the Communist Party realized that major economic and social distress would fracture the social contract if the country remains under the zero covid policy. And as a result, the zero COVID was jettisoned.
Amid the exponential rise in COVID-19 cases in China, the pharmaceutical industries are finding it difficult to cope with the high demand for medicines after the Xi Jinping-led government announced relaxations in its zero-Covid policy.
2022 was a momentous year for China, backstopped by an end-of-year scrabble to survive the pandemic of COVID-19 from December onwards. What the sequence of events taught the world is that the Chinese Communist Party (CCP) may be incredibly good at controlling its population, but it is not so
But it appears that his authoritarian rule is being questioned as the recent angry protests by the people across China over Xi's Zero-Covid policy is a crucial development.
China had its most difficult year under Xi's rule as it reeled from his costly zero-Covid policy - from months of overzealous enforcement that crushed the economy and stoked historic public discontent, to a wholesale abandonment so abrupt that left a fragile health system scrambling to cope
Turkish government which initially accepted Chinese vaccines is now scrutinising its efficacy after learning of China's involvement in data tempering of side effects only to enhance its vaccine sale.
This was well below forecast and seems to have been caused by lockdowns associated with its Zero Covid policy, the London-based consultancy said in a report.
Amid a surge in COVID-19 cases in the country, China on Monday announced to stop the coronavirus quarantine rule for inbound travellers from January 8.